Literature DB >> 23289765

CD40 ligand and interferon-γ induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes.

Georgiana M Klug-Micu1, Steffen Stenger, Andrea Sommer, Philip T Liu, Stephan R Krutzik, Robert L Modlin, Mario Fabri.   

Abstract

The ability of T cells to activate antimicrobial pathways in infected macrophages is essential to host defence against many intracellular pathogens. Here, we compared the ability of two T-cell-mediated mechanisms to trigger antimicrobial responses against Mycobacterium tuberculosis in humans, CD40 activation and the release of interferon-γ (IFN-γ). Given that IFN-γ activates a vitamin D-dependent antimicrobial response, we focused on induction of the key components of this pathway. We show that activation of human monocytes via CD40 ligand (CD40L) and IFN-γ, alone, and in combination, induces the CYP27b1-hydroxylase, responsible for the conversion of 25-hydroxyvitamin D (25D) to the bioactive 1,25-dihydroxyvitamin D (1,25D), and the vitamin D receptor (VDR). The activation of the vitamin D pathway by CD40L and IFN-γ results in up-regulated expression of the antimicrobial peptides, cathelicidin and DEFB4, as well as induction of autophagy. Finally, activation of monocytes via CD40L and IFN-γ results in an antimicrobial activity against intracellular M. tuberculosis. Our data suggest that at least two parallel T-cell-mediated mechanisms, CD40L and IFN-γ, activate the vitamin D-dependent antimicrobial pathway and trigger antimicrobial activity against intracellular M. tuberculosis, thereby contributing to human host defence against intracellular infection.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23289765      PMCID: PMC3634544          DOI: 10.1111/imm.12062

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection.

Authors:  Vanja Lazarevic; Amy J Myers; Charles A Scanga; JoAnne L Flynn
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

2.  Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction.

Authors:  U Shu; M Kiniwa; C Y Wu; C Maliszewski; N Vezzio; J Hakimi; M Gately; G Delespesse
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

3.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

Authors:  P Salgame; J S Abrams; C Clayberger; H Goldstein; J Convit; R L Modlin; B R Bloom
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

4.  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.

Authors:  J P DiSanto; J Y Bonnefoy; J F Gauchat; A Fischer; G de Saint Basile
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

5.  Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.

Authors:  Sarah M Fortune; Alejandra Solache; Alejandra Jaeger; Preston J Hill; John T Belisle; Barry R Bloom; Eric J Rubin; Joel D Ernst
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

6.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

7.  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.

Authors:  U Korthäuer; D Graf; H W Mages; F Brière; M Padayachee; S Malcolm; A G Ugazio; L D Notarangelo; R J Levinsky; R A Kroczek
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

8.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

Authors:  A Aruffo; M Farrington; D Hollenbaugh; X Li; A Milatovich; S Nonoyama; J Bajorath; L S Grosmaire; R Stenkamp; M Neubauer
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

9.  Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help).

Authors:  S Lederman; M J Yellin; A Krichevsky; J Belko; J J Lee; L Chess
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

10.  CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

Authors:  M R Alderson; R J Armitage; T W Tough; L Strockbine; W C Fanslow; M K Spriggs
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  37 in total

1.  Polymorphism of X-linked CD40 ligand gene associated with pulmonary tuberculosis in the Han Chinese population.

Authors:  C-Y Hu; X-A Zhang; C G Meyer; T Thye; W Liu; W-C Cao
Journal:  Genes Immun       Date:  2015-06-04       Impact factor: 2.676

2.  IL-32 is a molecular marker of a host defense network in human tuberculosis.

Authors:  Dennis Montoya; Megan S Inkeles; Phillip T Liu; Susan Realegeno; Rosane M B Teles; Poorva Vaidya; Marcos A Munoz; Mirjam Schenk; William R Swindell; Rene Chun; Kathryn Zavala; Martin Hewison; John S Adams; Steve Horvath; Matteo Pellegrini; Barry R Bloom; Robert L Modlin
Journal:  Sci Transl Med       Date:  2014-08-20       Impact factor: 17.956

3.  Identification of Signaling Pathways by Which CD40 Stimulates Autophagy and Antimicrobial Activity against Toxoplasma gondii in Macrophages.

Authors:  Elizabeth Liu; Yalitza Lopez Corcino; Jose-Andres C Portillo; Yanling Miao; Carlos S Subauste
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

4.  Interferon Gamma Reprograms Host Mitochondrial Metabolism through Inhibition of Complex II To Control Intracellular Bacterial Replication.

Authors:  Forrest Jessop; Robert Buntyn; Benjamin Schwarz; Tara Wehrly; Dana Scott; Catharine M Bosio
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

5.  Imatinib Triggers Phagolysosome Acidification and Antimicrobial Activity against Mycobacterium bovis Bacille Calmette-Guérin in Glucocorticoid-Treated Human Macrophages.

Authors:  Julia Steiger; Alexander Stephan; Megan S Inkeles; Susan Realegeno; Heiko Bruns; Philipp Kröll; Juliana de Castro Kroner; Andrea Sommer; Marina Batinica; Lena Pitzler; Rainer Kalscheuer; Pia Hartmann; Georg Plum; Steffen Stenger; Matteo Pellegrini; Bent Brachvogel; Robert L Modlin; Mario Fabri
Journal:  J Immunol       Date:  2016-05-27       Impact factor: 5.422

6.  Adjunctive interferon-γ immunotherapy in a pediatric case of Aspergillus terreus infection.

Authors:  Eemke L Assendorp; Mark S Gresnigt; Evelien G G Sprenkeler; Jacques F Meis; Natasja Dors; Jan W M van der Linden; Stefanie S V Henriet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-19       Impact factor: 3.267

Review 7.  Autophagy as an immune effector against tuberculosis.

Authors:  Steven B Bradfute; Eliseo F Castillo; John Arko-Mensah; Santosh Chauhan; Shanya Jiang; Michael Mandell; Vojo Deretic
Journal:  Curr Opin Microbiol       Date:  2013-06-18       Impact factor: 7.934

8.  LL37:DNA complexes provide antimicrobial activity against intracellular bacteria in human macrophages.

Authors:  Alexander Stephan; Marina Batinica; Julia Steiger; Pia Hartmann; Frank Zaucke; Wilhelm Bloch; Mario Fabri
Journal:  Immunology       Date:  2016-08       Impact factor: 7.397

Review 9.  Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS.

Authors:  Rene F Chun; Nancy Q Liu; T Lee; Joan I Schall; Michelle R Denburg; Richard M Rutstein; John S Adams; Babette S Zemel; Virginia A Stallings; Martin Hewison
Journal:  J Steroid Biochem Mol Biol       Date:  2014-08-01       Impact factor: 4.292

Review 10.  Cell-autonomous effector mechanisms against mycobacterium tuberculosis.

Authors:  John D MacMicking
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-31       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.